-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Börse FrankfurtISIN US4781601046-
Johnson & JohnsonBörse Börse FrankfurtISIN US4781601046Symbol JNJ
-
Johnson & JohnsonBörse Börse StuttgartSymbol JNJ
-
Johnson & JohnsonBörse Börse MünchenSymbol JNJ
-
Johnson & JohnsonBörse Börse BerlinSymbol JNJ
-
JOHNSON & JOHNSONBörse Xetra FrankfurtSymbol JNJ
-
JOHNSON & JOHNSONBörse Gettex System der Börse MünchenSymbol JNJ
-
JOHNSON & JOHNSONBörse Tradegate System der Deutsche Börse AG (60%)Symbol JNJ
-
JOHNSON & JOHNSONBörse Quotrix System der Börse DüsseldorfSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse DüsseldorfSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse HamburgSymbol JNJ
-
Johnson & JohnsonBörse SGO
-
Johnson & JohnsonBörse BUE
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Johnson & JohnsonBörse SSE
-
Zahlte zuletzt am 25.05.2021 eine Dividende von 1,06 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 14,66 % p. a.
beim aktuellen Kurs von 137,58 EUR +0,02%
Aktionärsstruktur der Johnson & Johnson
Portrait der Johnson & Johnson Aktie
Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.
Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor MSCI USA Quality UCITS ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
2.131 News & Informationen zur Johnson & Johnson Aktie
Upbeat earnings, recovery optimism lift Wall Street at open
Wall Street’s main indexes opened higher on Wednesday as upbeat quarterly results from companies including Johnson & Johnson and Coca-Cola reignited optimism…
Verizon Communications : Thinking about trading options or stock in MicroStrategy, Johnson & Johnson, Carnival Corp, BioNTech, or Verizon?
NEW YORK, July 21, 2021 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for MSTR, JNJ, CCL, BNTX, and VZ.
… | July 21, 2021
Global Anti-Inflammatory Therapeutics Market to Reach $125.55 Billion by 2028: AMR
Rise in prevalence of autoimmune diseases and chronic respiratory conditions, advent of new drugs, and surge in adoption rate of anti-inflammatory drugs…
Momentive Announces New SurveyMonkey Enterprise In-Meeting Feedback App for Zoom
With the new app, SurveyMonkey Enterprise customers will capture optimal stakeholder feedback when it matters and take action to enhance the in-meeting…
Momentive Announces New SurveyMonkey Enterprise In-Meeting Feedback App For Zoom
SAN MATEO, Calif., July 21, 2021 (GLOBE NEWSWIRE) — Momentive (Nasdaq: MNTV), an agile experience management company, today announced the launch of its
Market Talk – July 21, 2021
ASIA: China has scrapped its population control policy. Families in China can have as many children as they like without facing fines or other consequences. The
Time to Grab an Umbrella
Today’s bubble is “more insane” and “broader” than the dotcom bubble…
Aktien New York Ausblick: Positiver Auftakt im Dow – Netflix überschattet Techs
An der Wall Street zeichnet sich am Mittwoch ein gemischter Handelsauftakt ab: Die grossen Standardwerte dürften weiter auf der Erholungswelle reiten und positive Impulse aus Berichtssaison mitnehmen, die nun in den…
Upbeat earnings, recovery optimism set S&P 500, Dow for higher open
The S&P 500 and Dow indexes were set to rise on Wednesday as upbeat quarterly results from companies including Johnson & Johnson and Coca-Cola reignited…
This technical support shows the strength of the buy-the-dip force in markets
The firepower driving this market harder is a tough one to bet against.
Why Novavax Stock Should Continue To Rally
Novavax stock has rallied by almost 12% over the last week (five trading days), compared to the S&P 500 which was down by almost 3% over the same period. The stock is also up by a solid 85% year-to-date. The recent outperformance comes on the back of a broader rally in Covid vaccine stocks…
Energy Report: API Mystery
Commodities Analysis by Phil Flynn covering: Johnson & Johnson, Crude Oil WTI Futures, Natural Gas Futures. Read Phil Flynn's latest article on Investing.com
Mixed Earnings News May Lead To Mixed Open On Wall Street
The major U.S. index futures are currently pointing to a mixed open on Wednesday, with the major averages likely to move in opposite directions after ending the previous session sharply higher.
Futures Pointing To Mixed Open On Wall Street
After ending the previous session sharply higher, the major U.S. stock indexes may move in opposite directions in early trading on Wednesday. The major index futures are currently pointing to a mixed open, with the Dow futures up by 131 points but the Nasdaq futures down by 22 points.
Wednesday Morning Reads
Wednesday Morning Reads
South African firm to make Pfizer vaccine, first in Africa
Pfizer says a South African firm will begin producing the Pfizer/BioNTech COVID-19 vaccine
Johnson & Johnson wird nach starkem Quartal optimistischer
Für das bereinigte Ergebnis je Aktie gibt der Konzern nur ein Jahresziel inklusive Impfstoffgeschäft an: Demnach soll der bereinigte Gewinn um 19,6 bis 20,8 Prozent auf 9,60 bis 9,70 Dollar je Anteilsschein steigen. Bisher hatte die Obergrenze der Prognose bei 9,57 Dollar gelegen./knd/stw (AWP)
Johnson & Johnson posts higher profit as healthcare demand returns
Company raises guidance for rest of the year as Covid-19 vaccination campaign continues
Opinion: More employers should mandate COVID-19 vaccines for workers — for the health of their business
If businesses want to operate reliable in-person workplaces and attract customers, they must embrace the solution that government has so far shied away from.
Netflix Falls Premarket; Coca-Cola, Verizon and Chipotle Rise By Investing.com
Netflix Falls Premarket; Coca-Cola, Verizon and Chipotle Rise
J&J forecasts $2.5 billion in Covid vaccine sales
Johnson & Johnson has today forecast just $2.5 billion in 2021 sales of its Covid-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as it deals with vaccine production issues and safety concerns.
Pfizer, BioNTech join halting effort to produce covid-19 vaccines in Africa
Drugmakers face growing pressure from U.S., Europe to address global vaccine inequity
HC2 Holdings Provides $15 Million Series C Investment to Portfolio Company R2 Technologies
Investment to Expand Corporate Footprint and Accelerate Glacial Rx™ Commercialization…
Pharmakonzern: Johnson & Johnson steigert Umsatz und Gewinn und hebt Prognose an
Seite 1: Der Pharmakonzern hat im zweiten Quartal seinen Nettogewinn fast verdoppelt. Der Corona-Impfstoff dürfte für Einnahmen in Milliardenhöhe sorgen.
5 things to know before the stock market opens Wednesday
Dow futures rose Wednesday as Wall Street tried to keep its rebound rally going. Nasdaq futures slipped.
Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 8.77% and 4.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Johnson & Johnson raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales
The J&J shot, once touted as an important tool for vaccinations in hard-to-reach areas, has already delayed deliveries in the United States and Europe.
Johnson & Johnson Posts Higher Profit as Healthcare Demand Returns
Greater demand for medical devices, drugs and consumer-health products helped boost sales for the company in the latest quarter.
J&J raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Upbeat earnings, recovery optimism lift Wall St futures
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
J&J Gains On Revising Guidance After Medical Devices Boost In Q2 By Investing.com
J&J Gains On Revising Guidance After Medical Devices Boost In Q2
Johnson & Johnson boosts 2021 guidance after Q2 earnings beat (NYSE:JNJ)
Johnson & Johnson (JNJ) is trading ~1.0% higher in the pre-market after the company reported better-than-expected Q2 2021 financial results and lifted its 2021
Dow Futures 140 Pts Higher; Netflix Disappoints With Growth Forecast By Investing.com
Dow Futures 140 Pts Higher; Netflix Disappoints With Growth Forecast
Johnson & Johnson Raises FY21 View Above Market As Q2 Results Top Estimates
Drug major Johnson & Johnson on Wednesday raised its forecast for fiscal 2021 earnings and revenues above market view, after reporting strong growth in second-quarter results.
10 things before the opening bell
Johannes Eisele/Getty Images Welcome to 10 Things Before the Opening Bell. If this was forwarded to you, sign up here. Plus, sign up here for…
Johnson & Johnson expects $2.5 billion in global sales from Covid vaccine this year
Global sales of the Covid vaccine in the quarter were $164 million.
Moderna : Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with… | July 21, 2021
Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year By Reuters
Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year
Netflix, Nord Stream, Earnings and Crude Inventories
Netflix, Nord Stream, Earnings and Crude Inventories – What's Moving Markets
Johnson & Johnson Beats Earnings Forecast; Vaccine Sales Top $160 Million
Johnson & Johnson posted stronger-than-expected second quarter earnings Wednesday, while boosting its full-year profit forecast, as solid rebounds in pharmaceutical and consumer health sales boosted the group's top and bottom lines.